Silji Abraham - 29 Oct 2024 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Reporting relationship
SVP, Chief Technology Officer
Issuer ticker
WST
Reported as of
29 Oct 2024
Net transaction value
-$57,388
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 Oct 2024, 11:50:15 UTC
Prior SEC filing
13 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Louis Lalli

Key filing fact

Silji Abraham filed Form 4 for WEST PHARMACEUTICAL SERVICES INC (WST) on 31 Oct 2024.

Key facts

  • This page summarizes Silji Abraham's Form 4 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 31 Oct 2024, 11:50.

Change

  • Previous filing in this sequence was filed on 13 Jun 2024.
  • Current net transaction value: -$57,388.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WST transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+458
Change %
+16%
Price
$0.000000
Shares after
3,318
Date
29 Oct 2024
Ownership
Direct
WST transaction

Common Stock

Tax liability

Transaction value
$57,388
Shares
-180
Change %
-5.4%
Price
$318.41
Shares after
3,138
Date
29 Oct 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WST transaction Derivative

Rst. Stock Unit

Options Exercise

Transaction value
$0
Shares
-458
Change %
-100%
Price
$0.000000
Shares after
0
Date
29 Oct 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
458
Exercise price
$0.000000
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These units were payable in cash or the company's common stock upon the lapse of restrictions on the transaction date shown.

Footnote F2

Release of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .